Skip to main content
Atrás
Watch Compare

20/20 Biolabs, Inc.

Calidad de datos: 100%
AIDX
Nasdaq Services Engineering & Management Services
$1.90
▼ $0.02 (-0.78%)
Cap. Mercado: 19.84 M
Precio
$1.90
Cap. Mercado
19.84 M
Rango del Día
$1.73 — $1.99
Rango de 52 Semanas
$1.51 — $50.00
Volumen
55,543
Apertura $1.87
Promedio 50D / 200D
$4.01
52.56% below
Promedio 50D / 200D
$4.01
52.56% below

Quick Summary

Puntos Clave

Negative free cash flow of -1.92 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROIC-157.17%
Net Margin-182.82%
Op. Margin-162.87%

Seguridad

Debt / Equity
N/A
Current Ratio0.60
Interest Coverage-21.32

Valoración

PE (TTM)
-5.31
Below sector avg (-0.01)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Services (20 pares)
Métrica Acción Mediana del Sector
P/E -5.3 0.0
P/B — 3.1
ROE % — -1.5
Net Margin % -182.8 -0.3
Rev Growth 5Y % — 19.1
D/E — 1.0

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.05 M Net Income (TTM) -3.74 M
ROE N/A ROA -90.37%
Gross Margin 29.56% Operating Margin -162.87%
Net Margin -182.82% Free Cash Flow (TTM) -1.92 M
ROIC -157.17% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.60
Interest Coverage -21.32 Asset Turnover 0.49
Working Capital -992,008 Tangible Book Value -221,489
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5.31 Forward P/E N/A
P/B Ratio N/A P/S Ratio 9.70
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -9.68%
Market Cap 19.84 M Enterprise Value 18.82 M
Per Share
EPS (Diluted TTM) -0.76 Revenue / Share 0.20
FCF / Share -0.18 OCF / Share -0.18
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 51.35%
SBC-Adj. FCF -2.44 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue 2.05 M
Net Income -3.74 M
EPS (Diluted) -0.76
Gross Profit 604,541.0
Operating Income -3.33 M
EBITDA —
R&D Expenses 592,569.0
SG&A Expenses 3.34 M
D&A 63,257.0
Interest Expense 156,207.0
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 4.14 M
Total Liabilities 4.16 M
Shareholders' Equity -19,225.0
Total Debt —
Cash & Equivalents 1.03 M
Current Assets 1.47 M
Current Liabilities 2.46 M